搜尋結果
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections
CNBC· 7 日前... Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections< ... ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 6 日前A patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk ...
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Forbes· 2 日前Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular ...
Chinese team reports patient’s diabetes cured with cell therapy in world first
South China Morning Post· 5 小時前The patient received the innovative cell transplant in July 2021. Eleven weeks after the ...
Insurance funds boosting tech
China Daily· 5 小時前The company went public on the STAR Market at the Shanghai exchange in July 2019, making it one ...
'Asset famine' in China curbs central bank's bond trading ambitions
Reuters· 4 小時前A scarcity of low-risk assets in China's financial sector is obstructing the central ...
China’s ‘most handsome’ scientist, 87, shrugs off obsession over good looks
South China Morning Post· 6 小時前Recently, a photo of him when he was young went viral due to his striking resemblance to ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 3 日前Eli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting ...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 2 日前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform
The Wall Street Journal· 7 日前shares soared after the company said it would add injectable weight-loss drugs to its platform, ...